ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve
NCT ID: NCT06491758
Last Updated: 2025-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2020-06-02
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve -B
NCT06827548
Effect of Stimulation on the Vagus Nerve
NCT04206540
Vagus Nerve Response in Gastroparesis Patients
NCT04207996
Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus Nerve
NCT02159586
Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2
NCT06783504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects will also complete health history questionnaires.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Subjects
Subjects who have no gastric symptoms or conditions
ML1101 Stimulus Isolator
Electrical stimulation electrodes will be placed on the ear with the intensity of the current being increased by 10 percent every 60 seconds, the subject will grade the intensity of the current on a scale of 0-10. Increasing of the current will occur until the subject reports a comfortable level. Once the target level has been achieved the stimulation will be delivered for 2 minutes.
Vagal Maneuver
Subjects will undergo the following procedures to stimulate the vagus nerve.
* Cough: 6 to 8 forceful coughs
* Cold stimulus: a washcloth soaked in ice water will be placed on the face for 10 seconds.
* Carotid massage
* Gagging: a tongue depressor will be inserted for 10 seconds into the mouth touching the back of the mouth.
* Valsalva maneuver: subjects will will be asked to bear down as if they were having a bowel movement. They will be asked to blow through a mouthpiece that is hooked to a machine that measures how hard they are blowing.
* Eating: Subjects will be asked to drink water ( 8oz or 1 cup) or/ and Ensure Original ( 8 oz or 1 cup) that has 220 calories after fasting overnight to see that effect on vagal activity during eating.
Gastroparesis Subjects
Subjects with a confirmed diagnosis of gastroparesis.
ML1101 Stimulus Isolator
Electrical stimulation electrodes will be placed on the ear with the intensity of the current being increased by 10 percent every 60 seconds, the subject will grade the intensity of the current on a scale of 0-10. Increasing of the current will occur until the subject reports a comfortable level. Once the target level has been achieved the stimulation will be delivered for 2 minutes.
Vagal Maneuver
Subjects will undergo the following procedures to stimulate the vagus nerve.
* Cough: 6 to 8 forceful coughs
* Cold stimulus: a washcloth soaked in ice water will be placed on the face for 10 seconds.
* Carotid massage
* Gagging: a tongue depressor will be inserted for 10 seconds into the mouth touching the back of the mouth.
* Valsalva maneuver: subjects will will be asked to bear down as if they were having a bowel movement. They will be asked to blow through a mouthpiece that is hooked to a machine that measures how hard they are blowing.
* Eating: Subjects will be asked to drink water ( 8oz or 1 cup) or/ and Ensure Original ( 8 oz or 1 cup) that has 220 calories after fasting overnight to see that effect on vagal activity during eating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ML1101 Stimulus Isolator
Electrical stimulation electrodes will be placed on the ear with the intensity of the current being increased by 10 percent every 60 seconds, the subject will grade the intensity of the current on a scale of 0-10. Increasing of the current will occur until the subject reports a comfortable level. Once the target level has been achieved the stimulation will be delivered for 2 minutes.
Vagal Maneuver
Subjects will undergo the following procedures to stimulate the vagus nerve.
* Cough: 6 to 8 forceful coughs
* Cold stimulus: a washcloth soaked in ice water will be placed on the face for 10 seconds.
* Carotid massage
* Gagging: a tongue depressor will be inserted for 10 seconds into the mouth touching the back of the mouth.
* Valsalva maneuver: subjects will will be asked to bear down as if they were having a bowel movement. They will be asked to blow through a mouthpiece that is hooked to a machine that measures how hard they are blowing.
* Eating: Subjects will be asked to drink water ( 8oz or 1 cup) or/ and Ensure Original ( 8 oz or 1 cup) that has 220 calories after fasting overnight to see that effect on vagal activity during eating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-80 years
* Willing to have electrodes placed in the external ear (ABVN arm)
* Willing to perform vagal activity maneuver (Vagal arm)
* Willing to have 1 tablespoon (15 ml) of blood drawn at 3 time points
* Gastroparesis subjects with a confirmed diagnosis of gastroparesis from a GI physician
* Have a formal diagnosis of gastroparesis or are seeing the GI physician for symptoms related to gastroparesis
* Aged 18-80 years
* Willing to have electrodes placed in the external ear (ABVN arm)
* Willing to perform vagal activity maneuver (Vagal arm)
* Willing to have 1 tablespoon (15 ml) of blood drawn at 3 time points
Exclusion Criteria
* Pregnant females
* Prisoners
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas V. Nowak
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas V Nowak, MD
Role: PRINCIPAL_INVESTIGATOR
Indiana University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indiana University
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006075899- A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.